Peripheral Arterial Disease (PAD) Clinical Trial
Official title:
A Phase II, Open Label, Randomized, Multicenter Trial Comparing Noncontrast MRA Versus Ferumoxytol Vascular Enhanced MRI (VE-MRI) for the Detection of Clinically Significant Stenosis or Occlusion of the Aortoiliac and Superficial Femoral Arteries in Subjects With Peripheral Arterial Disease Scheduled for Digital Subtraction Angiography (DSA)
The purpose of this study is to compare the difference between two magnetic resonance imaging (MRI) techniques for visualizing arteries. The study hypothesizes that one method that relies upon imaging flowing blood in the pelvic and leg arteries will not be as accurate or efficient as injecting a safe imaging agent to change the appearance of the blood on the MRI. Both methods will be compared with Digital Subtraction Angiography (DSA).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01175850 -
Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease
|
N/A | |
Completed |
NCT00760565 -
A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).
|
Phase 1 | |
Recruiting |
NCT04631848 -
ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease
|
||
Completed |
NCT00196066 -
Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)
|
Phase 2 | |
Recruiting |
NCT05834673 -
VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
|
Phase 4 | |
Recruiting |
NCT05498740 -
Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
|
N/A | |
Completed |
NCT02780349 -
Evaluation of WIRION™ EPS in Lower Extremities Arteries
|
N/A | |
Completed |
NCT02254837 -
Zilver PTX Post-Market Study in Japan
|
N/A | |
Completed |
NCT02254356 -
Zilver Flex Post-Market Study in Japan
|
N/A | |
Completed |
NCT00689377 -
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention
|
N/A | |
Active, not recruiting |
NCT05149664 -
A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD
|
N/A | |
Recruiting |
NCT04749732 -
Home-based Exercise Therapy for Patients With PAD
|
N/A | |
Completed |
NCT02936622 -
Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
|
N/A | |
Completed |
NCT00827619 -
Zilver® Flex™ Vascular Stent Study
|
N/A | |
Completed |
NCT00862420 -
Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease
|
Phase 3 | |
Completed |
NCT04753372 -
Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk
|
||
Not yet recruiting |
NCT06457685 -
Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial
|
N/A | |
Recruiting |
NCT05246410 -
A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.
|
N/A | |
Terminated |
NCT03111238 -
The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
|
Phase 3 | |
Terminated |
NCT03174522 -
The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
|
Phase 3 |